跳至主要内容
临床试验/CTRI/2021/02/031594
CTRI/2021/02/031594尚未招募不适用

To assess the sensitization potential of skin care and hair care formulations on healthy human subjects.

Kama Ayurveda Pvt Ltd1 个研究点 分布在 1 个国家目标入组 120 人开始时间: 2021年2月28日最近更新:

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
120
试验地点
1
主要终点
Safety assessment of products

研究概览

简要总结

Objective: The objective of this study is to evaluate the sensitization potential of Skin Care formulations on healthy human subjects

Population of 120 healthy subjects (60 males + 60 females)

The test area is checked for erythema and oedema caused due to the products.

T0, T2, T4, T7, T9, T11, T14, T16, T18 – Patch Application

T1, T3, T5, T8, T10, T12, T15, T17, T19 – Patch Removal

T2, T4, T6, T9, T11, T13, T16, T18, T20 - 24-hour post patch removal grading

14 DAYS RESTING PHASE

T21 – Patch Application

T22 – Patch Removal

T23 - 24 hour post patch removal grading

T24 - 48 hour post patch removal grading

T25 - 72 hour post patch removal grading

研究设计

研究类型
Interventional
分配方式
Not Applicable
盲法
Not Applicable

入排标准

年龄范围
18.00 Year(s) 至 65.00 Year(s)(—)
性别
All

入选标准

  • Skin is healthy on the studied anatomic unit (free of eczema, wounds, inflammatory scar….) Subjects willing to come for regular follow up and ready to follow instructions during the study period.

排除标准

  • For female: Being pregnant or breastfeeding or having stopped to breastfeed in the past three months, Having refused to give his/her assent by signing the consent form, Taking part in another study liable to interfere with this study Being diabetic, Being asthmatic, Having eczema, Poriasis, lichen plan, vitiligo whatever the considered area, Having disorder of the healing (whatever the considered area), Having a rhinitis, allergic conjunctivitis or rhinosinusitis.

结局指标

主要结局

Safety assessment of products

时间窗: T0, T2, T4, T7, T9, T11, T14, T16, T18 – Patch Application | T1, T3, T5, T8, T10, T12, T15, T17, T19 – Patch Removal | T2, T4, T6, T9, T11, T13, T16, T18, T20 - 24-hour post patch removal grading | 14 DAYS RESTING PHASE | T21 – Patch Application | T22 – Patch Removal | T23 - 24 hour post patch removal grading | T24 - 48 hour post patch removal grading | T25 - 72 hour post patch removal grading

次要结局

未报告次要终点

研究者

发起方
Kama Ayurveda Pvt Ltd
申办方类型
Other [fmcg]

研究点 (1)

Loading locations...

相似试验